Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: A biomarker of blood–cerebrospinal fluid barrier permeability

This publication has 33 references indexed in Scilit:

• Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease
  Clinical Chemistry, 2009
• Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis
  Brain, 2009
• Phospholipase A₂-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly
  The Neuroscientist, 2006
• Secretory phospholipases A2 in inflammatory and allergic diseases: Not just enzymes
  Journal of Allergy and Clinical Immunology, 2005
• Cytosolic phospholipase A2α–deficient mice are resistant to experimental autoimmune encephalomyelitis
  Journal of Experimental Medicine, 2005
• IMMUNOLOGY OF MULTIPLE SCLEROSIS
  Annual Review of Immunology, 2005
• Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease
  Neuron, 2004
• Extracellular phospholipase A₂ inhibitors suppress central nervous system inflammation
  Glia, 2003
• Blood-Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major Depression
  Alzheimer Disease & Associated Disorders, 1997
• Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values
  Scandinavian Journal of Clinical and Laboratory Investigation, 1977